Literature DB >> 7698537

Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue.

F Raulf1, J Pérez, D Hoyer, C Bruns.   

Abstract

Somatostatin regulates endocrine and exocrine secretion, acts as a neurotransmitter/neuro-modulator and possesses antiproliferative properties. These diverse physiological effects are mediated by G-protein coupled receptors of which at least five subtypes have been cloned (SSTR1-5). Here, we have investigated the tissue distribution pattern of mRNAs encoding the five SRIF receptor subtypes in the adult rat by RT-PCR analysis and in situ hybridization histochemistry. All five receptor subtypes were found to be expressed simultaneously in brain and pituitary by RT-PCR. Besides, the in situ hybridization results clearly show a distinct but overlapping expression pattern of SSTR1-5 mRNA in the central nervous system as was found by RT-PCR for the periphery. Such distinct SRIF receptor expression may contribute to the selective biological functions of the receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698537     DOI: 10.1159/000201201

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

1.  SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.

Authors:  Sayed Hossein Hashemi; Jia-Yi Li; Håkan Ahlman; Annica Dahlström
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

3.  Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.

Authors:  E S McKeen; W Feniuk; A D Michel; E J Kidd; P P Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.

Authors:  P Cordelier; J P Estève; C Bousquet; N Delesque; A M O'Carroll; A V Schally; N Vaysse; C Susini; L Buscail
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Somatostatin sst2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa.

Authors:  M A Wyatt; E Jarvie; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Somatostatin receptors in the ventral pallidum/substantia innominata modulate rat locomotor activity.

Authors:  A Marazioti; A Kastellakis; K Antoniou; D Papasava; K Thermos
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

7.  DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.

Authors:  Damian Wild; Jörg S Schmitt; Mihaela Ginj; Helmut R Mäcke; Bert F Bernard; Eric Krenning; Marion De Jong; Sandra Wenger; Jean-Claude Reubi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-21       Impact factor: 9.236

8.  Somatostatin increases rat locomotor activity by activating sst(2) and sst (4) receptors in the striatum and via glutamatergic involvement.

Authors:  Stratos Santis; Andreas Kastellakis; Dimitra Kotzamani; Kalliopi Pitarokoili; Despoina Kokona; Kyriaki Thermos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-03       Impact factor: 3.000

9.  Activation of somatostatin receptors in the globus pallidus increases rat locomotor activity and dopamine release in the striatum.

Authors:  A Marazioti; P M Pitychoutis; Z Papadopoulou-Daifoti; C Spyraki; K Thermos
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

10.  Immunohistochemical distribution and subcellular localization of the somatostatin receptor subtype 1 (sst1) in the rat hypothalamus.

Authors:  Thomas Stroh; Philippe Sarret; Gloria S Tannenbaum; Alain Beaudet
Journal:  Neurochem Res       Date:  2006-03-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.